SL
ALT icon

Savior LLC’s Altimmune ALT Stock Holding History

Savior LLC’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-39
Closed -$1K – 845
2021
Q1 		$1K Buy
+39
New +$631 ﹤0.01% 797

Other funds holding ALT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Savior LLC's ALT Position: Q2 2021 in Review

Savior LLC sold out of Altimmune (ALT) in Q2 2021, closing a stake of 39 shares — an estimated $1K sold.

Savior LLC first reported a position in ALT in Q1 2021 and held it in 1 quarter. The position peaked at $1K in Q1 2021. 109 funds tracked by Wall St. Rank hold ALT as of Q2 2021.

  • Savior LLC reported no remaining Altimmune position as of Q2 2021 after selling out during the quarter.
  • Savior LLC sold 39 Altimmune shares in Q2 2021, an estimated $1K.
  • Savior LLC first reported a position in Altimmune in Q1 2021 and held it in 1 quarter.
  • Savior LLC's Altimmune position peaked at $1K in Q1 2021.
  • 109 funds tracked by Wall St. Rank held Altimmune as of Q2 2021.

Based on Savior LLC's 13F filing for Q2 2021, filed 9 Jul 2021.